MS data sharing during the coronavirus pandemic.
This week, MedDay Pharmaceuticals announced that the second pivotal Phase 3 trial (SPI2) of MD1003 (biotin), an investigational product for primary and secondary progressive MS has failed to meet its primary and secondary endpoints.
MS Index highlights severe lack of specialist healthcare services for people living with MS in Ireland
The Futureproofing Healthcare MS Index focuses on the treatment of MS across 30 European countries, with Ireland ranking in bottom third overall
A cognitive occupation-based programme for people with multiple sclerosis: A randomised controlled pilot trial to improve cognition and daily functioning for people with multiple sclerosis.
Bladder dysfunction and management strategies among people with Multiple sclerosis (MS): a qualitative study of people with MS perspectives
Cognitive Occupation Based Programme
MS talks at the 2019 Annual Conference in Limerick
The European Commission is hosting a survey consultation on the current European Disability Strategy
The European Medicines Agency has issued a press release recommending that Gilenya (fingolimod) not be used during pregnancy or by women of child-baring age who are not using effective contraception.